Inventor · disambiguated record
Charles Flynn
Also filed as: FLYNN CHARLES · FLYNN CHARLES ROBB
2 granted patents·7 pending applications·0 citations·filing 2016–2025
30Inventor score
Top patents by PatentIndex Score
9 records- 0174US12383515B2Compositions and methods of use of γ-ketoaldehyde scavengers for treating, preventing or improving nonalcoholic fatty liver disease (NAFLD), NASH, ALD or conditions related to the liverMTI BIOTECH INC·Filed 2022·Granted Aug 12, 2025·0 cites·6 claims
- 0274US2025360094A1Compositions and methods of use of gamma-ketoaldehyde scavengers for treating, preventing or improving nonalcoholic fatty liver disease (nafld), nash, ald or conditions related to the liverMTI BIOTECH INC·Filed 2025·Application pending·0 cites
- 0371US2018153827A1Compositions and methods of use of gamma-ketoaldehyde scavengers for treating, preventing or improving nonalcoholic fatty liver disease (nafld), nash, ald or conditions related to the liverMETABOLIC TECH INC·Filed 2017·Application pending·0 cites
- 0467US2023330049A1Compositions and methods of use of gamma-ketoaldheyde scavengers for treating, preventing or improving fibrosis of the liverMTI BIOTECH INC·Filed 2023·Application pending·0 cites
- 0555US2021023032A1Compositions and methods of use of gamma-ketoaldheyde scavengers for treating, preventing or improving fibrosis of the liverMTI BIOTECH INC·Filed 2020·Application pending·0 cites
- 0647US2022143158A1Duodenal administration of botulinum toxinUNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 0743US2019099387A1Compositions and methods of use of gamma-ketoaldheyde scavengers for treating, preventing or improving fibrosis of the liverMETABOLIC TECH INC·Filed 2018·Application pending·0 cites
- 0838US10064876B2Bile acid receptor agonism for treating addictionUNIV VANDERBILT·Filed 2016·Granted Sep 4, 2018·0 cites·4 claims
- 0937US2018360851A1Bile acid receptor agonism for treating addictionUNIV VANDERBILT·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charles Flynn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →